7:10 PM
 | 
Jun 15, 2015
 |  BC Extra  |  Financial News

Avalon, GSK launch three more biotechs

Avalon Ventures and GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) launched three build-to-buy companies, each with $3 million in series A funding and $7 million in R&D support....

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >